These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1441732)

  • 1. Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen.
    Newland JW; Hale TL; Formal SB
    Vaccine; 1992; 10(11):766-76. PubMed ID: 1441732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains.
    Alexander WA; Hartman AB; Oaks EV; Venkatesan MM
    Vaccine; 1996 Aug; 14(11):1053-61. PubMed ID: 8879102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.
    Kotloff KL; Herrington DA; Hale TL; Newland JW; Van De Verg L; Cogan JP; Snoy PJ; Sadoff JC; Formal SB; Levine MM
    Infect Immun; 1992 Jun; 60(6):2218-24. PubMed ID: 1587589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.
    Formal SB; Hale TL; Kapfer C; Cogan JP; Snoy PJ; Chung R; Wingfield ME; Elisberg BL; Baron LS
    Infect Immun; 1984 Nov; 46(2):465-9. PubMed ID: 6389344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
    Kärnell A; Cam PD; Verma N; Lindberg AA
    Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
    Koprowski H; Levine MM; Anderson RJ; Losonsky G; Pizza M; Barry EM
    Infect Immun; 2000 Sep; 68(9):4884-92. PubMed ID: 10948101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain.
    Venkatesan M; Fernandez-Prada C; Buysse JM; Formal SB; Hale TL
    Vaccine; 1991 May; 9(5):358-63. PubMed ID: 1872021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.
    Noriega FR; Wang JY; Losonsky G; Maneval DR; Hone DM; Levine MM
    Infect Immun; 1994 Nov; 62(11):5168-72. PubMed ID: 7927802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
    Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
    Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.
    Fält IC; Schweda EK; Klee S; Singh M; Floderus E; Timmis KN; Lindberg AA
    J Bacteriol; 1995 Sep; 177(18):5310-5. PubMed ID: 7545156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
    Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
    Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri.
    Levine MM; Woodward WE; Formal SB; Gemski P; DuPont HL; Hornick RB; Snyder MJ
    J Infect Dis; 1977 Oct; 136(4):577-82. PubMed ID: 333041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates.
    Ranallo RT; Fonseka S; Boren TL; Bedford LA; Kaminski RW; Thakkar S; Venkatesan MM
    Vaccine; 2012 Jul; 30(34):5159-71. PubMed ID: 22658966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes.
    Verma NK; Lindberg AA
    Vaccine; 1991 Jan; 9(1):6-9. PubMed ID: 2008803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An auxotrophic live oral Shigella flexneri vaccine: development and testing.
    Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP; Cam PD; Trach DD; Lindberg AA
    Rev Infect Dis; 1991; 13 Suppl 4():S357-61. PubMed ID: 2047663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
    Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA
    Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2.
    Taylor DN; Phillip DF; Zapor M; Trofa A; Van de Verg L; Hartman A; Bendiuk N; Newland JW; Formal SB; Sadoff JC
    Vaccine; 1994 May; 12(6):565-8. PubMed ID: 8036831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine.
    Lindberg AA; Karnell A; Pál T; Sweiha H; Hultenby K; Stocker BA
    Microb Pathog; 1990 Jun; 8(6):433-40. PubMed ID: 2266855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.